Opinion
Recent advances in pathophysiology and management of subglottic Hemangioma
Mohamed Khamis Tolba Mahmoud Abdalla*
Published: 04 May, 2018 | Volume 2 - Issue 1 | Pages: 006-007
Subglottic hemangioma is the most common vascular tumor of the larynx of pediatrics; in contrast, it is relatively uncommon, accounting for an estimated 1.5% of congenital laryngeal anomalies [1].
Read Full Article HTML
DOI: 10.29328/journal.ated.1001005
Cite this Article
Read Full Article PDF
References
- Holinger PH, Brown WT. Congenital webs, cysts, laryngoceles and other anomalies of the larynx. Ann Otol Rhinol Laryngol. 1967; 76: 744-752. Ref.: https://goo.gl/yp7SnN
- Itinteang T, Brasch HD, Day DJ, Tan ST. Renin-angiotensin system in hemangioma. Presented at the 18th International Workshop on Vascular Anomalies. 2010.
- North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000; 31: 11-22. Ref.: https://goo.gl/byVezL
- Badi AN, Kerschner JE, North PE, Drolet BA, Messner A, et al. Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int J Pediatr Otorhinolaryngol. 2009; 73: 1187-1191. Ref.: https://goo.gl/xc6q3w
- Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008; 358: 2649-2651. Ref.: https://goo.gl/Y4ajtw
- Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg. 2011; 64: 292-299. Ref.: https://goo.gl/BfKFcN
- Denoyelle F, Garabédian EN. Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas. Otolaryngol Head Neck Surg. 2010; 142: 463-464. Ref.: https://goo.gl/HrQ69a
- Kräling BM, Razon MJ, Boon LM, Zurakowski D, Seachord C, et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol. 1996; 148: 1181-1191. Ref.: https://goo.gl/tD3fdW
- Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997; 13: 375-423. Ref.: https://goo.gl/uP4KeL
- Ohlms LA, Jones DT, McGill TJ, Healy GB. Interferon alfa-2a therapy for airway hemangiomas. Ann Otol Rhinol Laryngol. 1994; 103: 1-8. Ref.: https://goo.gl/wFzDX4
- Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992; 326: 1456-1463. Ref.: https://goo.gl/bFmKt2